Improving HIV therapy with drug resistance genotyping: The Viradapt Study

J. Durant; P. Clevenbergh; P. Halfon; P. Delguidice; S. Porsin; E. Dohin; J.M. Schapiro; C.A.B. Boucher; P. Dellamonica

Improving HIV therapy with drug resistance genotyping: The Viradapt Study

Translated title of the contribution: Improving HIV therapy with drug resistance genotyping: The Viradapt Study

J. Durant, P. Clevenbergh, P. Halfon, P. Delguidice, S. Porsin, E. Dohin, J.M. Schapiro, C.A.B. Boucher, P. Dellamonica

Department of Medical Microbiology

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Improving HIV therapy with drug resistance genotyping: The Viradapt Study
Original language	Undefined/Unknown
Pages (from-to)	2195-2199
Number of pages	5
Journal	The Lancet
Volume	353
Publication status	Published - 1999

Cite this

@article{3923dd77cb6c4f0f9b37800cc25633fe,

title = "Improving HIV therapy with drug resistance genotyping: The Viradapt Study",

author = "J. Durant and P. Clevenbergh and P. Halfon and P. Delguidice and S. Porsin and E. Dohin and J.M. Schapiro and C.A.B. Boucher and P. Dellamonica",

year = "1999",

language = "Undefined/Unknown",

volume = "353",

pages = "2195--2199",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Improving HIV therapy with drug resistance genotyping: The Viradapt Study

AU - Durant, J.

AU - Clevenbergh, P.

AU - Halfon, P.

AU - Delguidice, P.

AU - Porsin, S.

AU - Dohin, E.

AU - Schapiro, J.M.

AU - Boucher, C.A.B.

AU - Dellamonica, P.

PY - 1999

Y1 - 1999

M3 - Article

SN - 0140-6736

VL - 353

SP - 2195

EP - 2199

JO - The Lancet

JF - The Lancet

ER -